9-127897971-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_013443.5(ST6GALNAC6):c.11C>T(p.Ser4Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000158 in 1,596,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_013443.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ST6GALNAC6 | NM_013443.5 | c.11C>T | p.Ser4Leu | missense_variant | 2/7 | ENST00000373146.6 | NP_038471.2 | |
ST6GALNAC4-ST6GALNAC6-AK1 | NR_174625.1 | n.903-1639C>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ST6GALNAC6 | ENST00000373146.6 | c.11C>T | p.Ser4Leu | missense_variant | 2/7 | 1 | NM_013443.5 | ENSP00000362239 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152084Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000127 AC: 30AN: 236766Hom.: 0 AF XY: 0.000140 AC XY: 18AN XY: 128760
GnomAD4 exome AF: 0.000163 AC: 236AN: 1444272Hom.: 0 Cov.: 26 AF XY: 0.000159 AC XY: 114AN XY: 718790
GnomAD4 genome AF: 0.000105 AC: 16AN: 152084Hom.: 0 Cov.: 32 AF XY: 0.000108 AC XY: 8AN XY: 74266
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 20, 2023 | The c.11C>T (p.S4L) alteration is located in exon 2 (coding exon 1) of the ST6GALNAC6 gene. This alteration results from a C to T substitution at nucleotide position 11, causing the serine (S) at amino acid position 4 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at